Silver Lining or Dark Cloud? FDA Approves First Drug for Duchenne Muscular Dystrophy

On September 19, 2016, the U.S. Food and Drug Administration (FDA) granted accelerated marketing approval to Exondys 51 (eteplirsen; Sarepta Therapeutics, Cambridge, MA), the first drug approved to treat Duchenne muscular dystrophy (DMD), a debilitating, genetic disorder characterized by progressive muscle deterioration and weakness. FDA approved the drug to treat a specific form of DMD […]

Read more "Silver Lining or Dark Cloud? FDA Approves First Drug for Duchenne Muscular Dystrophy"

The Future of the Written Story

In the past several years, I have often heard people talk about how traditional writing in the form of stories and novels will soon be a thing of the past. The simple truth is, they say, people prefer immersive experiences, like movies and television. As technology continues to develop, and movie budgets continue to rise, […]

Read more "The Future of the Written Story"

Rise of the Machines: Artificial Intelligence Advances toward Consumer Healthcare

Since the dawn of the information age, the concept of artificial intelligence (AI) has spawned a number of popular stories that have been broadly inculcated into society’s collective unconscious. Many stories present AI as a sinister force, inevitably advancing beyond their creators’ control, ultimately becoming the master or destroyer of humankind. Others present AI as […]

Read more "Rise of the Machines: Artificial Intelligence Advances toward Consumer Healthcare"